Foundation Focus: June 2025 update with CEO Jorey Berry
Financial assistance programs can help with medical bills
Foundation sends letter opposing research cuts
How Medicaid cuts could impact a family affected by SCID
Lunch & Learn: Understanding genetic variants in APDS
Update: What RSV preventatives mean for those with PI
Genentech
Genentech is a leading biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases. Its transformational discoveries include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis.
Rocket scientist with CVID encourages others to pursue their passion
Jorey's monthly wrap-up: May 2025

